BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24088862)

  • 21. Comparison of real-time PCR techniques to cytotoxigenic culture methods for diagnosing Clostridium difficile infection.
    Knetsch CW; Bakker D; de Boer RF; Sanders I; Hofs S; Kooistra-Smid AM; Corver J; Eastwood K; Wilcox MH; Kuijper EJ
    J Clin Microbiol; 2011 Jan; 49(1):227-31. PubMed ID: 20980562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the cobas Cdiff Test for Detection of Toxigenic Clostridium difficile in Stool Samples.
    Peterson LR; Young SA; Davis TE; Wang ZX; Duncan J; Noutsios C; Liesenfeld O; Osiecki JC; Lewinski MA
    J Clin Microbiol; 2017 Dec; 55(12):3426-3436. PubMed ID: 28954901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Clostridium difficile toxin A/B genes by multiplex real-time PCR for the diagnosis of C. difficile infection.
    Kim H; Jeong SH; Kim M; Lee Y; Lee K
    J Med Microbiol; 2012 Feb; 61(Pt 2):274-277. PubMed ID: 21959205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of Clostridium difficile from faecal specimens--a comparison of chromID C. difficile agar and cycloserine-cefoxitin-fructose agar.
    Carson KC; Boseiwaqa LV; Thean SK; Foster NF; Riley TV
    J Med Microbiol; 2013 Sep; 62(Pt 9):1423-1427. PubMed ID: 23579394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR assays using toxigenic Clostridium difficile culture for direct detection of tcdB from stool specimens.
    Shin BM; Mun SJ; Yoo SJ; Kuak EY
    J Clin Microbiol; 2012 Nov; 50(11):3765-7. PubMed ID: 22952270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.
    Le Guern R; Herwegh S; Grandbastien B; Courcol R; Wallet F
    J Clin Microbiol; 2012 Sep; 50(9):3089-90. PubMed ID: 22760042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.
    Babady NE; Stiles J; Ruggiero P; Khosa P; Huang D; Shuptar S; Kamboj M; Kiehn TE
    J Clin Microbiol; 2010 Dec; 48(12):4519-24. PubMed ID: 20943860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection.
    Shin BM; Kuak EY; Lee EJ; Songer JG
    J Clin Microbiol; 2009 Sep; 47(9):2952-6. PubMed ID: 19625481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection.
    Karre T; Sloan L; Patel R; Mandrekar J; Rosenblatt J
    J Clin Microbiol; 2011 Feb; 49(2):725-7. PubMed ID: 21123537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of Clostridium difficile ribotype 027 in Korea.
    Kim H; Lee Y; Moon HW; Lim CS; Lee K; Chong Y
    Korean J Lab Med; 2011 Jul; 31(3):191-6. PubMed ID: 21779194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of laboratory tests for detection for Clostridioides difficile: A multicenter prospective study in Japan.
    Senoh M; Kato H; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
    Anaerobe; 2019 Dec; 60():102107. PubMed ID: 31647977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of clostridium difficile infections.
    Huang H; Weintraub A; Fang H; Nord CE
    J Clin Microbiol; 2009 Nov; 47(11):3729-31. PubMed ID: 19741082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.
    Boyanton BL; Sural P; Loomis CR; Pesta C; Gonzalez-Krellwitz L; Robinson-Dunn B; Riska P
    J Clin Microbiol; 2012 Mar; 50(3):640-5. PubMed ID: 22189114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection.
    Bruins MJ; Verbeek E; Wallinga JA; Bruijnesteijn van Coppenraet LE; Kuijper EJ; Bloembergen P
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3035-9. PubMed ID: 22706512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel one-step method for detection and isolation of active-toxin-producing Clostridium difficile strains directly from stool samples.
    Darkoh C; Dupont HL; Kaplan HB
    J Clin Microbiol; 2011 Dec; 49(12):4219-24. PubMed ID: 21976761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cost-effective approach for detection of toxigenic Clostridium difficile: toxigenic culture using ChromID Clostridium difficile agar.
    Luk S; To WK; Ng TK; Hui WT; Lee WK; Lau F; Ching AM
    J Clin Microbiol; 2014 Feb; 52(2):671-3. PubMed ID: 24478510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of Clostridium difficile: real-time PCR detection of toxin genes in faecal samples is more sensitive compared to toxigenic culture.
    Jensen MB; Olsen KE; Nielsen XC; Hoegh AM; Dessau RB; Atlung T; Engberg J
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):727-36. PubMed ID: 25421216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection.
    Sloan LM; Duresko BJ; Gustafson DR; Rosenblatt JE
    J Clin Microbiol; 2008 Jun; 46(6):1996-2001. PubMed ID: 18434563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of strain typing results for Clostridium difficile isolates from North America.
    Tenover FC; Akerlund T; Gerding DN; Goering RV; Boström T; Jonsson AM; Wong E; Wortman AT; Persing DH
    J Clin Microbiol; 2011 May; 49(5):1831-7. PubMed ID: 21389155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Automated detection of toxigenic Clostridium difficile in clinical samples: isothermal tcdB amplification coupled to array-based detection.
    Hicke B; Pasko C; Groves B; Ager E; Corpuz M; Frech G; Munns D; Smith W; Warcup A; Denys G; Ledeboer NA; Lindsey W; Owen C; Rea L; Jenison R
    J Clin Microbiol; 2012 Aug; 50(8):2681-7. PubMed ID: 22675134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.